Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2171-2180 of 2809 for

Edit search filters
  1. Multiple Myeloma Patient Registry

    Jacksonville, FL

  2. Ultrasensitive Detection of Target micro-RNAs and Nucleic Acids in Small Volume Blood Samples of Advanced Stage Prostate and Kidney Cancer Patients

    Jacksonville, FL, Rochester, MN

  3. Study of Validated Biomarkers in Urine for Patients with Adenocarcinoma of the Prostate

    Rochester, MN

  4. A Study Investigating Integrated Genomics and Patient-derived Cancer Models

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study to Isolate and Culture Bacteria from the Uterus that have been Connected to Endometrial Cancer

    Rochester, MN

  6. Biorepository for Acute Leukemia Research

    Rochester, MN

  7. Cardiotoxic Effects of Chemotherapy in Patients with Sarcomas

    Rochester, MN

  8. Pain Severity and Pain Interference Outcomes following Percutaneous MRI-Guided Laser Ablation and Cryoablation of Painful Peripheral, Soft Tissue Vascular Anomali

    Rochester, MN

  9. SULF1 and SULF2 Role in Cholangiocarcinoma

    Rochester, MN

  10. Use of Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy and Risk of Malignancy in Genetic Mutation Carriers

    Rochester, MN

.

Mayo Clinic Footer